ISA alert! I think GlaxoSmithKline is a great buy for both income and growth investing

With a potential Covid-19 vaccine and a high dividend yield, Jonathan Smith thinks his interest in both income and growth investing could be satisfied by GSK.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

As an ISA investor, I’m always on the lookout for good stocks to buy. The Stocks and Shares ISA allowance enables me to receive dividends gross of tax. It also enables me to pay no capital gains tax if I sell a stock for a profit within the ISA wrapper. This makes it a great tool for both income and growth investing. 

Some investors think that income or growth investing are mutually exclusive. This really isn’t the case. You can buy a stock that pays out a dividend, but also has growth prospects. It’s true that some high-growth, early-stage firms may not pay a dividend to help retain profits within the business. Yet there are still plenty of growing firms that do. 

Growth investing prospects

GlaxoSmithKline (LSE:GSK) is one of the largest pharmaceutical businesses in the world. It was formed by a merger of two companies in 2000, so isn’t tagged as an early-stage growth business. Yet due to the search for a vaccine, even a mature company like GSK has large share price appreciation potential.

Passive income stocks: our picks

Do you like the idea of dividend income?

The prospect of investing in a company just once, then sitting back and watching as it potentially pays a dividend out over and over?

If you’re excited by the thought of regular passive income payments, as well as the potential for significant growth on your initial investment…

Then we think you’ll want to see this report inside Motley Fool Share Advisor — ‘5 Essential Stocks For Passive Income Seekers’.

What’s more, today we’re giving away one of these stock picks, absolutely free!

Get your free passive income stock pick

This particularly appeals to growth investors. Since April, GSK has teamed up with Sanofi in a vaccine push. Even though it looks unlikely that they’ll be the first to develop a vaccine, this doesn’t render it pointless. The partnership has arguably the largest network to distribute such a vaccine around the world. Only last week, GSK made a commitment to supply 200m doses to COVAX. This is a group of governments, health groups and others formed to help with the response to the virus. 

The bottom line is that it looks likely the GSK/Sanofi vaccine will be a large-scale product, with huge demand (assuming it works). From a financial point of view, this could be very profitable. As a result, investors would likely see growth in the share price of GSK into the medium term. New developments of this scale don’t happen that often, and so the move could be significant.

Income prospects

Aside from growth investing, income investors also find value in buying GSK. In a recent Q3 trading update, the dividend of 19p per share was flat compared to last year. This doesn’t surprise me, given that the quarterly results were mixed, with the highlight being an increase in operating profit to £1.9bn. The flat dividend versus last year should actually give comfort to income investors. The opportunity to cut the dividend going into the year-end is one companies have often used in the past, to boost balance sheets.

The current dividend yield sits at 5.72%. This is very attractive when comparing it to the FTSE 100 average of 3.4%. When compared to the Bank of England base rate of 0.1%, it looks even more appealing. Having already considered the growth potential above, income investors can also potentially look forward to a profit aside from the dividend.

Overall, I feel GSK is a solid buy for income and growth investing. At present, I feel it offers the best of both worlds, given the situation we find ourselves in with the virus.

Our best passive income stock ideas

Do you like the idea of dividend income?

The prospect of investing in a company just once, then sitting back and watching as it potentially pays a dividend out over and over?

If you’re excited by the thought of regular passive income payments, as well as the potential for significant growth on your initial investment…

Then we think you’ll want to see this report inside Motley Fool Share Advisor — ‘5 Essential Stocks For Passive Income Seekers’.

What’s more, today we’re giving away one of these stock picks, absolutely free!

Get your free passive income stock pick

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

jonathansmith1 has no position in any of the shares mentioned. The Motley Fool UK has recommended GlaxoSmithKline. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Tree lined "tunnel" in the English countryside of West Sussex in autumn
Investing Articles

How should I invest to build retirement wealth in a SIPP for a child?

Ben McPoland explains how he plans to adapt his investing strategy in order to more reliably build wealth for his…

Read more »

Content white businesswoman being congratulated by colleagues at her retirement party
Investing Articles

Age 60 and looking for income? 3 FTSE 100 shares yielding 6%+ to consider

Harvey Jones picks out three FTSE 100 shares that offer a juicy passive income stream. Older investors should consider them,…

Read more »

UK money in a Jar on a background
Investing Articles

One of Britain’s best dividend shares is soaring! Time to buy?

Our writer's been looking for shares to buy. One of the biggest UK dividend payers has caught his eye. Could…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing Articles

£100, £1,000, or £100,000? Here’s how much it takes to start investing in shares!

Does it take a large sum of money for someone to start investing in the stock market? Our writer doesn't…

Read more »

Close-up of a woman holding modern polymer ten, twenty and fifty pound notes.
Investing Articles

£20,000 in an ISA? Here’s how it could target £1,250 a month in passive income

A Stocks and Shares ISA can be a platform for someone with spare cash to set up a sizeable second…

Read more »

Close-up as a woman counts out modern British banknotes.
Investing Articles

3 UK shares I own for easy passive income

Christopher Ruane runs through a diverse trio of UK shares he currently owns, each of which generates passive income in…

Read more »

UK coloured flags waving above large crowd on a stadium sport match.
Investing Articles

Is the UK-US trade deal a brilliant buying opportunity for FTSE 100 shares?

A long-awaited trade deal has been struck between the UK and the US, but how much will FTSE 100 stocks…

Read more »

UK supporters with flag
Investing Articles

3 growth stocks up 27% in a month to consider buying now

Stock market volatility has been a brilliant opportunity to buy growth stocks, which are now rebounding at speed. Harvey Jones…

Read more »